Entity family
Universities, hospitals, research centres, networks, and public bodies. Examples include universities, NHS trusts, research networks.
Showing 481–540 of 9,137, ordered by supporting articles. Choose a institution to see its evidence.
…trospective chart reviews of 239 patients diagnosed with SSc at Yokohama City University Hospital from January 2018 to March 2025. Clinical characteristics, labo…
…hical approval was granted by the Health Research Authority and Health and Care Research Wales (REC Reference 23/NW/0206). Participants diagnosed with a histo…
… and Methods We searched MEDLINE, Embase, CINAHL, PsycINFO, and CENTRAL from inception to 10 April 2024, with additional citation searc…
…f patients receiving Iloprost in a dedicated day-case unit at a tertiary SSc referral centre in London, UK was collected retrospectively over 6 months (Augu…
…ons.Material and Methods Clinical data of lcSSc patients in the Italian SPRING registry were retrospectively compared based on MMF use at any stage of …
…ods Patients from the European Scleroderma Trials and Research (EUSTAR) cohort with dcSSc, fulfilling ACR/EULAR classification criteri…
…ective analysis of all patients with morphea followed-up by the Department of Rheumatology and Clinical Immunology, Larissa, Greece was performed. Demographics and disease relate…
…ted for publication in Revista da Associação Médica Brasileira (RAMB), October 22, 2025. In press.Abstract P.223 Figure 1…
…inical subset of SSc were identified using LipidScreener 1.0.0 (Nova Medical Testing Inc.) and classified according to a three-tier identification method…
…l and Methods Adult patients with systemic sclerosis (SSc) from Maccabi Healthcare Services (MHS), a 2.7-million-member Israeli health provider, were ident…
…luated by AI-assisted analysis (Thoracic VCAR, AW SERVER v.3.2, GE Healthcare) and by two chest radiologists for semi-quantitative analysis o…
… The combined morbi-mortality endpoint from the MINIMISE trial (EudraCT: 2019-004139-21) was used as clinical outcome, with time-to-eve…